Renato Leão de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Renato Leão de Oliveira has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Arcuschin de Oliveira
Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), Rua Botucatu, 740, São Paulo 04023-062, SP, Brazil
1 shared publication - Daniel Eiger
Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland
1 shared publication - Mireille Darc Cavalcante Brandão
Clínica Professor Doutor Renato Santos, São Paulo (SP), Brazil
1 shared publication - Murilo Costa Sousa
Clínica Professor Doutor Renato Santos, São Paulo (SP), Brazil
1 shared publication - Renato Santos de Oliveira Filho
Universidade Federal de São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (4) , 553-558
Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review
Cutaneous melanoma is the solid neoplasia with the highest growing incidence among all tumors. It spreads predictably to the lymphatic vessels and sentinel lymph node, and when the latter is affected the prognosis worsens dramatically. Sentinel lymph node biopsy is considered when thickness of the primary tumor exceeds 1mm and/or when there are adverse features in thinner melanomas. When there is nodal metastasis, current evidence in the literature recommends complete lymphadenectomy, although this procedure has its intrinsic risks (i.e., lymphedema and cellulitis), and there are no published clinical trials proving additional overall survival benefits. The current in-depth literature review thus aims to identify patients that will benefit most from the procedure, including those with the highest likelihood of presenting additional affected lymph nodes in the same nodal basin. The authors also discuss techniques for identification of the sentinel lymph node, false-negative rates, and predictive models for lymph node involvement. In conclusion, complete elective lymphadenectomy should always be discussed on a case-by-case basis when metastases are detected in the sentinel lymph node.
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (4) , 553-558
Open AccessComplete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review
Cutaneous melanoma is the solid neoplasia with the highest growing incidence among all tumors. It spreads predictably to the lymphatic vessels and sentinel lymph node, and when the latter is affected the prognosis worsens dramatically. Sentinel lymph node biopsy is considered when thickness of the primary tumor exceeds 1mm and/or when there are adverse features in thinner melanomas. When there is nodal metastasis, current evidence in the literature recommends complete lymphadenectomy, although this procedure has its intrinsic risks (i.e., lymphedema and cellulitis), and there are no published clinical trials proving additional overall survival benefits. The current in-depth literature review thus aims to identify patients that will benefit most from the procedure, including those with the highest likelihood of presenting additional affected lymph nodes in the same nodal basin. The authors also discuss techniques for identification of the sentinel lymph node, false-negative rates, and predictive models for lymph node involvement. In conclusion, complete elective lymphadenectomy should always be discussed on a case-by-case basis when metastases are detected in the sentinel lymph node.